Darwin Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$190K Buy
525
+3
+0.6% +$1.03K 0.05% 141
2026
Q1
$184K Buy
522
+13
+3% +$4.63K 0.06% 141
2025
Q4
$167K Buy
509
+6
+1% +$1.9K 0.05% 143
2025
Q3
$142K Buy
503
+21
+4% +$6.09K 0.05% 149
2025
Q2
$135K Sell
482
-81
-14% -$22.9K 0.05% 144
2025
Q1
$147K Hold
563
0.05% 152
2024
Q4
$147K Sell
563
-116
-17% -$34.4K 0.05% 152
2024
Q3
$219K Buy
+679
New +$222K 0.06% 133
2024
Q1
Sell
-722
Closed -$208K 139
2023
Q4
$208K Sell
722
-59
-8% -$16.1K 0.06% 141
2023
Q3
$210K Buy
+781
New +$195K 0.06% 141
2020
Q4
Sell
-788
Closed -$200K 163
2020
Q3
$200K Sell
788
-73
-8% -$18.1K 0.04% 148
2020
Q2
$203K Sell
861
-50
-5% -$11.4K 0.05% 150
2020
Q1
$184K Buy
+911
New +$199K 0.06% 136
2019
Q2
Sell
-12,098
Closed -$2.3M 148
2019
Q1
$2.3M Buy
+12,098
New +$2.31M 0.76% 52
2016
Q3
Sell
-1,566
Closed -$238K 87
2016
Q2
$238K Buy
+1,566
New +$243K 0.2% 81

Other funds holding AMGN

Darwin Wealth Management's AMGN Position: Q2 2026 in Review

Darwin Wealth Management increased its Amgen (AMGN) stake by 0.57% in Q2 2026, buying an estimated $1.03K and bringing the position to 525 shares worth $190K. The position accounts for 0.05% of the portfolio, ranked #141.

Darwin Wealth Management first reported a position in AMGN in Q2 2016 and has held it in 15 quarters since. The position peaked at $2.3M in Q1 2019. 1,131 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Darwin Wealth Management held 525 shares of Amgen worth $190K as of Q2 2026.
  • Darwin Wealth Management bought 3 Amgen shares in Q2 2026, an estimated $1.03K.
  • Amgen made up 0.05% of Darwin Wealth Management's portfolio in Q2 2026, its #141 holding.
  • Darwin Wealth Management first reported a position in Amgen in Q2 2016 and has held it in 15 quarters since.
  • Darwin Wealth Management's Amgen position peaked at $2.3M in Q1 2019.
  • 1,131 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.